Universität zu Köln

Siemanowski, Janna, Heydt, Carina and Merkelbach-Bruse, Sabine (2020). Predictive molecular pathology of lung cancer in Germany with focus on gene fusion testing: Methods and quality assurance. Cancer Cytopathol., 128 (9). S. 611 - 622. HOBOKEN: WILEY. ISSN 1934-6638

Full text not available from this repository.

Abstract

Predictive molecular testing has become an important part of the diagnosis of any patient with lung cancer. Using reliable methods to ensure timely and accurate results is inevitable for guiding treatment decisions. In the past few years, parallel sequencing has been established for mutation testing, and its use is currently broadened for the detection of other genetic alterations, such as gene fusion and copy number variations. In addition, conventional methods such as immunohistochemistry and in situ hybridization are still being used, either for formalin-fixed, paraffin-embedded tissue or for cytological specimens. For the development and broad implementation of such complex technologies, interdisciplinary and regional networks are needed. The Network Genomic Medicine (NGM) has served as a model of centralized testing and decentralized treatment of patients and incorporates all German comprehensive cancer centers. Internal quality control, laboratory accreditation, and participation in external quality assessment is mandatory for the delivery of reliable results. Here, we provide a summary of current technologies used to identify patients who have lung cancer with gene fusions, briefly describe the structures of NGM and the national NGM (nNGM), and provide recommendations for quality assurance.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Siemanowski, Janna UNSPECIFIED UNSPECIFIED UNSPECIFIED Heydt, Carina UNSPECIFIED UNSPECIFIED UNSPECIFIED Merkelbach-Bruse, Sabine UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-321720
DOI:	10.1002/cncy.22293
Journal or Publication Title:	Cancer Cytopathol.
Volume:	128
Number:	9
Page Range:	S. 611 - 622
Date:	2020
Publisher:	WILEY
Place of Publication:	HOBOKEN
ISSN:	1934-6638
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language ANAPLASTIC LYMPHOMA KINASE; WORLDWIDE RING TRIAL; IMMUNOHISTOCHEMICAL DETECTION; TARGETED THERAPY; ALK; ROS1; REARRANGEMENTS; ADENOCARCINOMA; FISH; CRIZOTINIB Multiple languages Oncology; Pathology Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/32172